GlobalPost examines HIV/AIDS in Asia, Africa

As part of its series titled "The State of HIV/AIDS," GlobalPost published two stories examining the epidemic in different regions of the world. In one article, the news service looks at the spread and control of HIV in Asia, writing, "No generalized epidemic has broken out across the region, HIV infection rates have stabilized in many countries, and more and more people are receiving antiretroviral medication." However, "[t]he disease continues to spread: for every person in Asia that begins antiretroviral treatment, roughly two new adults are infected with HIV. Moreover, funding is too tight -- the total of $1.1 billion spent on campaigns in Asia in 2009 was less than one-third of what the U.N. says is needed for universal success," according to the news service (Carlson, 12/1). In a second article, GlobalPost says in Africa, "statistics tell an upbeat story," noting that the number of new HIV infections and AIDS-related deaths have fallen over the past decade. "But despite all the positive progress, experts warn against complacency. Sub-Saharan Africa still accounted for almost three-quarters of all new HIV infections worldwide last year," the news service continues (McConnell, 12/3).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Historical redlining continues to affect HIV treatment in affected communities